Leiomyosarcoma CT

Revision as of 20:31, 6 March 2019 by Nima Nasiri (talk | contribs)
Jump to navigation Jump to search

Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma CT

CDC on Leiomyosarcoma CT

Leiomyosarcoma CT in the news

Blogs on Leiomyosarcoma CT

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

The CT helps to assess the number and location of nodules in the lungs, invasion of the mediastinum and pleura, as well as spread to hilar and mediastinal lymph nodes. It can confirm the location of the sarcoma and show the organs nearby. These are helpful for determining the stage of cancer and in determining whether surgery is a good treatment option. CT scans can also be used to guide biopsy and a biopsy sample is usually removed and looked at under a microscope.

CT Scan

The CT helps to assess the number and location of nodules in the lungs, invasion of the mediastinum and pleura, as well as spread to hilar and mediastinal lymph nodes.[1] Morphological imaging features usually depends upon the site of the Leiomyosarcoma but generally it is suggestive of heterogeneous mass,demonstrating central low attenuation representing the necrosis and rarely with calcification.





References

  1. Rutkowski, Piotr; Ługowska, Iwona (2014). "Follow-up in soft tissue sarcomas". memo - Magazine of European Medical Oncology. 7 (2): 92–96. doi:10.1007/s12254-014-0146-8. ISSN 1865-5041.


Template:WikiDoc Sources